ERBB2 and ovarian carcinoma: Binding and internalization of the trastuzumab-polymer siRNA nanoparticle was confirmed by flow cytometry in both HER2-overexpressing SKOV3 ovarian cancer and SKBR3 breast cancer cells using fluorescent AlexaFluor 647 labelled siRNA (Figure 2).